Anti-PLA2R antibodies as a prognostic factor in PLA2R-related membranous nephropathy
SA Timmermans, MA Abdul Hamid… - American journal of …, 2015 - karger.com
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid… - American Journal …, 2015 - cris.maastrichtuniversity.nl
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid… - American journal …, 2015 - pubmed.ncbi.nlm.nih.gov
Background The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid… - American Journal of …, 2015 - search.proquest.com
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
[PDF][PDF] Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid, JWC Tervaert… - Am J …, 2015 - researchgate.net
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MA Abdul Hamid… - American Journal of …, 2015 - karger.com
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
[PDF][PDF] Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid, JWC Tervaert… - Am J Nephrol, 2015 - academia.edu
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
[PDF][PDF] Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid, JWC Tervaert… - Am J …, 2015 - scholar.archive.org
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
SA Timmermans, MAA Hamid, JWC Tervaert… - American Journal of …, 2015 - cir.nii.ac.jp
抄録< jats: p> Background: The natural course of idiopathic membranous nephropathy (MN)
varies, as it is known through favorable outcomes in most patients. However, one third of …
varies, as it is known through favorable outcomes in most patients. However, one third of …
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy.
SA Timmermans, A Hamid, CT JW… - American Journal of …, 2015 - europepmc.org
Background The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …
known through favorable outcomes in most patients. However, one third of patients with …